CytomX News

CytomX | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Global Healthcare Master Fund, LP(7.38%),Cormorant Global Healthcare GP, LLC(7.38%), etc.

16:06 ET

CytomX | 8-K: Current report

May 8 16:46 ET

CytomX | 8-K: CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 8 16:13 ET

CytomX | 10-Q: Quarterly report

May 8 16:06 ET

CytomX | DEFA14A: Others

May 1 06:14 ET

CytomX | DEFA14A: Others

Apr 4 16:37 ET

CytomX | DEF 14A: Definitive information statements

Apr 4 16:37 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Sean A.

Mar 28 19:15 ET

CytomX | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 25 17:20 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Su Zhen

Mar 22 16:33 ET

CytomX | 3: Initial statement of beneficial ownership of securities-Director Su Zhen

Mar 22 16:28 ET

CytomX | 8-K: Current report

Mar 22 16:11 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer ROWLAND LLOYD A

Mar 21 16:47 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer Ogden Christopher

Mar 21 16:47 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer BELVIN MARCIA

Mar 21 16:43 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Sean A.

Mar 21 16:42 ET

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer Landau Jeffrey B

Mar 21 16:42 ET

CytomX | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 11 16:33 ET

CytomX | 8-K: Current report

Mar 11 16:03 ET

CytomX | 10-K: Annual report

Mar 11 16:03 ET